Bloomberg IntelligenceBloomberg Intelligence

OPKO's Bishop on FDA Approval Of Its Kidney Disease Drug(Audio)

View descriptionShare

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Intelligence

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harnes 
Social links
Follow podcast
Recent clips
Browse 3,352 clip(s)